APO Research
Talk to an analyst

APO RESEARCH · REPORT

Agomelatine API

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Agomelatine API Market Analysis and Forecast 2026-2032

23 December 2025198 pages

Choose your research edition.

Industry ResearchAgomelatine API Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Agomelatine API Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Agomelatine API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Agomelatine API Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Agomelatine API Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Agomelatine API market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Agomelatine API's global sales reached XX (Tons) with a value of US$ XX Million, marking an change of XX% compared to the previous year. This performance has positioned Msn Pharmachem Private Ltd as the global sales leader, a title it has maintained for several consecutive years. Notably, Msn Pharmachem Private Ltd's performance in primary markets is also remarkable. In the Chinese market, sales were XX (Tons), a change of XX% from the previous year. In Europe, sales were XX (Tons), showing a year-on-year of XX%. In the US, sales were XX (Tons), a year-on-year change of XX%.

The major global manufacturers in the Agomelatine API market include Msn Pharmachem Private Ltd, Jiangsu Hansoh Pharmaceutical Group and Yangtze River Pharmaceutical, etc. In 2025, the top three vendors accounted for approximately % of the revenue.

Read the full market overview

In terms of production side, this report researches the Agomelatine API production, growth rate, market share by manufacturers and by region (region level and country level), from 2021 to 2026, and forecast to 2032.

In terms of consumption side, this report focuses on the sales of Agomelatine API by region (region level and country level), by Company, by Type and by Application. from 2021 to 2026 and forecast to 2032.

This report presents an overview of global market for Agomelatine API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Agomelatine API, also provides the consumption of main regions and countries. Of the upcoming market potential for Agomelatine API, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Agomelatine API sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Agomelatine API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Agomelatine API sales, projected growth trends, production technology, application and end-user industry.

Agomelatine API Segment by Company

Msn Pharmachem Private Ltd

Jiangsu Hansoh Pharmaceutical Group

Yangtze River Pharmaceutical

Agomelatine API Segment by Type

Purity ≥99%

98%≤purity≤99%

Agomelatine API Segment by Application

Tablets

Others

Agomelatine API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Agomelatine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Agomelatine API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Agomelatine API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Agomelatine API production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 4: Sales (consumption), revenue of Agomelatine API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 5: Detailed analysis of Agomelatine API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Agomelatine API sales, revenue, price, gross margin, and recent development, etc.

Chapter 9: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 10: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 11: China by type, by application, sales, and revenue for each segment.

Chapter 12: Asia (Excluding China) by type, by application and by region, sales, and revenue for each segment.

Chapter 13: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 14: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 15: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Agomelatine API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Purity ≥99% Major Manufacturers Table 3. 98%≤purity≤99% Major Manufacturers Table 4. Global Agomelatine API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Tablets Major Manufacturers Table 6. Others Major Manufacturers Table 7. Agomelatine API Industry Trends Table 8. Agomelatine API Industry Drivers Table 9. Agomelatine API Industry Opportunities and Challenges Table 10. Agomelatine API Industry Restraints Table 11. Global Agomelatine API Production Growth Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 12. Global Agomelatine API Production by Region (2021-2026) & (Tons) Table 13. Global Agomelatine API Production by Region (2027-2032) & (Tons) Table 14. Global Agomelatine API Production Market Share by Region (2021-2026) Table 15. Global Agomelatine API Production Market Share by Region (2027-2032) Table 16. Global Agomelatine API Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Agomelatine API Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Agomelatine API Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Agomelatine API Revenue Market Share by Region (2021-2026) Table 20. Global Agomelatine API Revenue Market Share by Region (2027-2032) Table 21. Global Agomelatine API Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 22. Global Agomelatine API Sales by Region (2021-2026) & (Tons) Table 23. Global Agomelatine API Sales by Region (2027-2032) & (Tons) Table 24. Global Agomelatine API Sales Market Share by Region (2021-2026) Table 25. Global Agomelatine API Sales Market Share by Region (2027-2032) Table 26. Global Agomelatine API Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Agomelatine API Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Agomelatine API Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Agomelatine API Sales Market Share by Manufacturers (2021-2026) Table 30. Global Agomelatine API Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 31. Global Agomelatine API Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Agomelatine API Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Agomelatine API Manufacturers, Product Type & Application Table 34. Global Agomelatine API Manufacturers Commercialization Time Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Agomelatine API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 37. Global Agomelatine API Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Agomelatine API Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Agomelatine API Revenue Market Share by Type (2021-2026) Table 40. Global Agomelatine API Revenue Market Share by Type (2027-2032) Table 41. Global Agomelatine API Sales by Type (2021-2026) & (Tons) Table 42. Global Agomelatine API Sales by Type (2027-2032) & (Tons) Table 43. Global Agomelatine API Sales Market Share by Type (2021-2026) Table 44. Global Agomelatine API Sales Market Share by Type (2027-2032) Table 45. Global Agomelatine API Price by Type (2021-2026) & (US$/Ton) Table 46. Global Agomelatine API Price by Type (2027-2032) & (US$/Ton) Table 47. Global Agomelatine API Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Agomelatine API Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Agomelatine API Revenue Market Share by Application (2021-2026) Table 50. Global Agomelatine API Revenue Market Share by Application (2027-2032) Table 51. Global Agomelatine API Sales by Application (2021-2026) & (Tons) Table 52. Global Agomelatine API Sales by Application (2027-2032) & (Tons) Table 53. Global Agomelatine API Sales Market Share by Application (2021-2026) Table 54. Global Agomelatine API Sales Market Share by Application (2027-2032) Table 55. Global Agomelatine API Price by Application (2021-2026) & (US$/Ton) Table 56. Global Agomelatine API Price by Application (2027-2032) & (US$/Ton) Table 57. Msn Pharmachem Private Ltd Company Information Table 58. Msn Pharmachem Private Ltd Business Overview Table 59. Msn Pharmachem Private Ltd Agomelatine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 60. Msn Pharmachem Private Ltd Agomelatine API Product Portfolio Table 61. Msn Pharmachem Private Ltd Recent Development Table 62. Jiangsu Hansoh Pharmaceutical Group Company Information Table 63. Jiangsu Hansoh Pharmaceutical Group Business Overview Table 64. Jiangsu Hansoh Pharmaceutical Group Agomelatine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 65. Jiangsu Hansoh Pharmaceutical Group Agomelatine API Product Portfolio Table 66. Jiangsu Hansoh Pharmaceutical Group Recent Development Table 67. Yangtze River Pharmaceutical Company Information Table 68. Yangtze River Pharmaceutical Business Overview Table 69. Yangtze River Pharmaceutical Agomelatine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Yangtze River Pharmaceutical Agomelatine API Product Portfolio Table 71. Yangtze River Pharmaceutical Recent Development Table 72. North America Agomelatine API Revenue by Type (2021-2026) & (US$ Million) Table 73. North America Agomelatine API Revenue by Type (2027-2032) & (US$ Million) Table 74. North America Agomelatine API Sales by Type (2021-2026) & (Tons) Table 75. North America Agomelatine API Sales by Type (2027-2032) & (Tons) Table 76. North America Agomelatine API Sales Price by Type (2021-2026) & (US$/Ton) Table 77. North America Agomelatine API Sales Price by Type (2027-2032) & (US$/Ton) Table 78. North America Agomelatine API Revenue by Application (2021-2026) & (US$ Million) Table 79. North America Agomelatine API Revenue by Application (2027-2032) & (US$ Million) Table 80. North America Agomelatine API Sales by Application (2021-2026) & (Tons) Table 81. North America Agomelatine API Sales by Application (2027-2032) & (Tons) Table 82. North America Agomelatine API Sales Price by Application (2021-2026) & (US$/Ton) Table 83. North America Agomelatine API Sales Price by Application (2027-2032) & (US$/Ton) Table 84. North America Agomelatine API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 85. North America Agomelatine API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 86. North America Agomelatine API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 87. North America Agomelatine API Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 88. North America Agomelatine API Sales by Country (2021-2026) & (Tons) Table 89. North America Agomelatine API Sales by Country (2027-2032) & (Tons) Table 90. North America Agomelatine API Sales Price by Country (2021-2026) & (US$/Ton) Table 91. North America Agomelatine API Sales Price by Country (2027-2032) & (US$/Ton) Table 92. United States Agomelatine API Revenue (2021-2032) & (US$ Million) Table 93. Canada Agomelatine API Revenue (2021-2032) & (US$ Million) Table 94. Mexico Agomelatine API Revenue (2021-2032) & (US$ Million) Table 95. Europe Agomelatine API Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe Agomelatine API Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe Agomelatine API Sales by Type (2021-2026) & (Tons) Table 98. Europe Agomelatine API Sales by Type (2027-2032) & (Tons) Table 99. Europe Agomelatine API Sales Price by Type (2021-2026) & (US$/Ton) Table 100. Europe Agomelatine API Sales Price by Type (2027-2032) & (US$/Ton) Table 101. Europe Agomelatine API Revenue by Application (2021-2026) & (US$ Million) Table 102. Europe Agomelatine API Revenue by Application (2027-2032) & (US$ Million) Table 103. Europe Agomelatine API Sales by Application (2021-2026) & (Tons) Table 104. Europe Agomelatine API Sales by Application (2027-2032) & (Tons) Table 105. Europe Agomelatine API Sales Price by Application (2021-2026) & (US$/Ton) Table 106. Europe Agomelatine API Sales Price by Application (2027-2032) & (US$/Ton) Table 107. Europe Agomelatine API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Europe Agomelatine API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. Europe Agomelatine API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. Europe Agomelatine API Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 111. Europe Agomelatine API Sales by Country (2021-2026) & (Tons) Table 112. Europe Agomelatine API Sales by Country (2027-2032) & (Tons) Table 113. Europe Agomelatine API Sales Price by Country (2021-2026) & (US$/Ton) Table 114. Europe Agomelatine API Sales Price by Country (2027-2032) & (US$/Ton) Table 115. Germany Agomelatine API Revenue (2021-2032) & (US$ Million) Table 116. France Agomelatine API Revenue (2021-2032) & (US$ Million) Table 117. U.K. Agomelatine API Revenue (2021-2032) & (US$ Million) Table 118. Italy Agomelatine API Revenue (2021-2032) & (US$ Million) Table 119. Russia Agomelatine API Revenue (2021-2032) & (US$ Million) Table 120. Spain Agomelatine API Revenue (2021-2032) & (US$ Million) Table 121. Netherlands Agomelatine API Revenue (2021-2032) & (US$ Million) Table 122. Switzerland Agomelatine API Revenue (2021-2032) & (US$ Million) Table 123. Sweden Agomelatine API Revenue (2021-2032) & (US$ Million) Table 124. Poland Agomelatine API Revenue (2021-2032) & (US$ Million) Table 125. China Agomelatine API Revenue by Type (2021-2026) & (US$ Million) Table 126. China Agomelatine API Revenue by Type (2027-2032) & (US$ Million) Table 127. China Agomelatine API Sales by Type (2021-2026) & (Tons) Table 128. China Agomelatine API Sales by Type (2027-2032) & (Tons) Table 129. China Agomelatine API Sales Price by Type (2021-2026) & (US$/Ton) Table 130. China Agomelatine API Sales Price by Type (2027-2032) & (US$/Ton) Table 131. China Agomelatine API Revenue by Application (2021-2026) & (US$ Million) Table 132. China Agomelatine API Revenue by Application (2027-2032) & (US$ Million) Table 133. China Agomelatine API Sales by Application (2021-2026) & (Tons) Table 134. China Agomelatine API Sales by Application (2027-2032) & (Tons) Table 135. China Agomelatine API Sales Price by Application (2021-2026) & (US$/Ton) Table 136. China Agomelatine API Sales Price by Application (2027-2032) & (US$/Ton) Table 137. Asia Agomelatine API Revenue by Type (2021-2026) & (US$ Million) Table 138. Asia Agomelatine API Revenue by Type (2027-2032) & (US$ Million) Table 139. Asia Agomelatine API Sales by Type (2021-2026) & (Tons) Table 140. Asia Agomelatine API Sales by Type (2027-2032) & (Tons) Table 141. Asia Agomelatine API Sales Price by Type (2021-2026) & (US$/Ton) Table 142. Asia Agomelatine API Sales Price by Type (2027-2032) & (US$/Ton) Table 143. Asia Agomelatine API Revenue by Application (2021-2026) & (US$ Million) Table 144. Asia Agomelatine API Revenue by Application (2027-2032) & (US$ Million) Table 145. Asia Agomelatine API Sales by Application (2021-2026) & (Tons) Table 146. Asia Agomelatine API Sales by Application (2027-2032) & (Tons) Table 147. Asia Agomelatine API Sales Price by Application (2021-2026) & (US$/Ton) Table 148. Asia Agomelatine API Sales Price by Application (2027-2032) & (US$/Ton) Table 149. Asia Agomelatine API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. Asia Agomelatine API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 151. Asia Agomelatine API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 152. Asia Agomelatine API Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 153. Asia Agomelatine API Sales by Country (2021-2026) & (Tons) Table 154. Asia Agomelatine API Sales by Country (2027-2032) & (Tons) Table 155. Asia Agomelatine API Sales Price by Country (2021-2026) & (US$/Ton) Table 156. Asia Agomelatine API Sales Price by Country (2027-2032) & (US$/Ton) Table 157. Japan Agomelatine API Revenue (2021-2032) & (US$ Million) Table 158. South Korea Agomelatine API Revenue (2021-2032) & (US$ Million) Table 159. India Agomelatine API Revenue (2021-2032) & (US$ Million) Table 160. Australia Agomelatine API Revenue (2021-2032) & (US$ Million) Table 161. Taiwan Agomelatine API Revenue (2021-2032) & (US$ Million) Table 162. Southeast Asia Agomelatine API Revenue (2021-2032) & (US$ Million) Table 163. SAMEA Agomelatine API Revenue by Type (2021-2026) & (US$ Million) Table 164. SAMEA Agomelatine API Revenue by Type (2027-2032) & (US$ Million) Table 165. SAMEA Agomelatine API Sales by Type (2021-2026) & (Tons) Table 166. SAMEA Agomelatine API Sales by Type (2027-2032) & (Tons) Table 167. SAMEA Agomelatine API Sales Price by Type (2021-2026) & (US$/Ton) Table 168. SAMEA Agomelatine API Sales Price by Type (2027-2032) & (US$/Ton) Table 169. SAMEA Agomelatine API Revenue by Application (2021-2026) & (US$ Million) Table 170. SAMEA Agomelatine API Revenue by Application (2027-2032) & (US$ Million) Table 171. SAMEA Agomelatine API Sales by Application (2021-2026) & (Tons) Table 172. SAMEA Agomelatine API Sales by Application (2027-2032) & (Tons) Table 173. SAMEA Agomelatine API Sales Price by Application (2021-2026) & (US$/Ton) Table 174. SAMEA Agomelatine API Sales Price by Application (2027-2032) & (US$/Ton) Table 175. SAMEA Agomelatine API Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. SAMEA Agomelatine API Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. SAMEA Agomelatine API Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. SAMEA Agomelatine API Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 179. SAMEA Agomelatine API Sales by Country (2021-2026) & (Tons) Table 180. SAMEA Agomelatine API Sales by Country (2027-2032) & (Tons) Table 181. SAMEA Agomelatine API Sales Price by Country (2021-2026) & (US$/Ton) Table 182. SAMEA Agomelatine API Sales Price by Country (2027-2032) & (US$/Ton) Table 183. Brazil Agomelatine API Revenue (2021-2032) & (US$ Million) Table 184. Argentina Agomelatine API Revenue (2021-2032) & (US$ Million) Table 185. Chile Agomelatine API Revenue (2021-2032) & (US$ Million) Table 186. Colombia Agomelatine API Revenue (2021-2032) & (US$ Million) Table 187. Peru Agomelatine API Revenue (2021-2032) & (US$ Million) Table 188. Saudi Arabia Agomelatine API Revenue (2021-2032) & (US$ Million) Table 189. Israel Agomelatine API Revenue (2021-2032) & (US$ Million) Table 190. UAE Agomelatine API Revenue (2021-2032) & (US$ Million) Table 191. Turkey Agomelatine API Revenue (2021-2032) & (US$ Million) Table 192. Iran Agomelatine API Revenue (2021-2032) & (US$ Million) Table 193. Egypt Agomelatine API Revenue (2021-2032) & (US$ Million) Table 194. Key Raw Materials Table 195. Raw Materials Key Suppliers Table 196. Agomelatine API Distributors List Table 197. Agomelatine API Customers List Table 198. Research Programs/Design for This Report Table 199. Authors List of This Report Table 200. Secondary Sources Table 201. Primary Sources List of Figures Figure 1. Agomelatine API Product Image Figure 2. Global Agomelatine API Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Agomelatine API Market Size Share 2021 VS 2025 VS 2032 Figure . Purity ≥99% Image Figure 1. 98%≤purity≤99% Image Figure 2. Global Agomelatine API Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Agomelatine API Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tablets Image Figure 5. Others Image Figure 6. Global Agomelatine API Capacity, Capacity Utilization (2021-2032) & (Tons) Figure 7. Global Agomelatine API Production by Region: 2021 VS 2025 VS 2032 (Tons) Figure 8. Global Agomelatine API Production Market Share by Region: 2025 Versus 2032 Figure 9. Global Agomelatine API Production Market Share by Region (2021-2032) Figure 10. North America Agomelatine API Production Growth Rate (2021-2032) & (Tons) Figure 11. Europe Agomelatine API Production Growth Rate (2021-2032) & (Tons) Figure 12. China Agomelatine API Production Growth Rate (2021-2032) & (Tons) Figure 13. Japan Agomelatine API Production Growth Rate (2021-2032) & (Tons) Figure 14. Global Agomelatine API Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Agomelatine API Revenue (2021-2032) & (US$ Million) Figure 16. Global Agomelatine API Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Agomelatine API Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Agomelatine API Revenue Market Share by Region (2021-2032) Figure 19. Global Agomelatine API Sales (2021-2032) & (Tons) Figure 20. Global Agomelatine API Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 21. Global Agomelatine API Sales Market Share by Region (2021-2032) Figure 22. North America Agomelatine API Sales YoY (2021-2032) & (Tons) Figure 23. Europe Agomelatine API Sales YoY (2021-2032) & (Tons) Figure 24. China Agomelatine API Sales YoY (2021-2032) & (Tons) Figure 25. Asia (Excluding China) Agomelatine API Sales YoY (2021-2032) & (Tons) Figure 26. South America, Middle East and Africa Agomelatine API Sales YoY (2021-2032) & (Tons) Figure 27. Global Agomelatine API Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Agomelatine API Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Agomelatine API Revenue Market Share by Type (2021-2032) Figure 31. Global Agomelatine API Sales Market Share by Type (2021-2032) Figure 32. Global Agomelatine API Revenue Market Share by Application (2021-2032) Figure 33. Global Agomelatine API Sales Market Share by Application (2021-2032) Figure 34. North America Agomelatine API Revenue Share by Type (2021-2032) Figure 35. North America Agomelatine API Sales Share by Type (2021-2032) Figure 36. North America Agomelatine API Revenue Share by Application (2021-2032) Figure 37. North America Agomelatine API Sales Share by Application (2021-2032) Figure 38. North America Agomelatine API Revenue Share by Country (2021-2032) Figure 39. North America Agomelatine API Sales Share by Country (2021-2032) Figure 40. Europe Agomelatine API Revenue Share by Type (2021-2032) Figure 41. Europe Agomelatine API Sales Share by Type (2021-2032) Figure 42. Europe Agomelatine API Revenue Share by Application (2021-2032) Figure 43. Europe Agomelatine API Sales Share by Application (2021-2032) Figure 44. Europe Agomelatine API Revenue Share by Country (2021-2032) Figure 45. Europe Agomelatine API Sales Share by Country (2021-2032) Figure 46. China Agomelatine API Revenue Share by Type (2021-2032) Figure 47. China Agomelatine API Sales Share by Type (2021-2032) Figure 48. China Agomelatine API Revenue Share by Application (2021-2032) Figure 49. China Agomelatine API Sales Share by Application (2021-2032) Figure 50. Asia Agomelatine API Revenue Share by Type (2021-2032) Figure 51. Asia Agomelatine API Sales Share by Type (2021-2032) Figure 52. Asia Agomelatine API Revenue Share by Application (2021-2032) Figure 53. Asia Agomelatine API Sales Share by Application (2021-2032) Figure 54. Asia Agomelatine API Revenue Share by Country (2021-2032) Figure 55. Asia Agomelatine API Sales Share by Country (2021-2032) Figure 56. SAMEA Agomelatine API Revenue Share by Type (2021-2032) Figure 57. SAMEA Agomelatine API Sales Share by Type (2021-2032) Figure 58. SAMEA Agomelatine API Revenue Share by Application (2021-2032) Figure 59. SAMEA Agomelatine API Sales Share by Application (2021-2032) Figure 60. SAMEA Agomelatine API Revenue Share by Country (2021-2032) Figure 61. SAMEA Agomelatine API Sales Share by Country (2021-2032) Figure 62. Agomelatine API Value Chain Figure 63. Manufacturing Cost Structure Figure 64. Agomelatine API Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Purity ≥99%
  • 98%≤purity≤99%
Applications
  • Tablets
  • Others
Companies covered
  • Msn Pharmachem Private Ltd
  • Jiangsu Hansoh Pharmaceutical Group
  • Yangtze River Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Agomelatine API Market by Type
  3. 1.2.1 Global Agomelatine API Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Purity ≥99%
  5. 1.2.3 98%≤purity≤99%
  6. 1.3 Agomelatine API Market by Application
  7. 1.3.1 Global Agomelatine API Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Tablets
  9. 1.3.3 Others
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Agomelatine API Market Dynamics
  1. 2.1 Agomelatine API Industry Trends
  2. 2.2 Agomelatine API Industry Drivers
  3. 2.3 Agomelatine API Industry Opportunities and Challenges
  4. 2.4 Agomelatine API Industry Restraints
3 Global Agomelatine API Production Overview
  1. 3.1 Global Agomelatine API Production Capacity (2021-2032)
  2. 3.2 Global Agomelatine API Production by Region: 2021 VS 2025 VS 2032
  3. 3.3 Global Agomelatine API Production by Region
  4. 3.3.1 Global Agomelatine API Production by Region (2021-2026)
  5. 3.3.2 Global Agomelatine API Production by Region (2027-2032)
  6. 3.3.3 Global Agomelatine API Production Market Share by Region (2021-2032)
  7. 3.4 North America
  8. 3.5 Europe
  9. 3.6 China
  10. 3.7 Japan
4 Global Market Growth Prospects
  1. 4.1 Global Agomelatine API Revenue Estimates and Forecasts (2021-2032)
  2. 4.2 Global Agomelatine API Revenue by Region
  3. 4.2.1 Global Agomelatine API Revenue by Region: 2021 VS 2025 VS 2032
  4. 4.2.2 Global Agomelatine API Revenue by Region (2021-2026)
  5. 4.2.3 Global Agomelatine API Revenue by Region (2027-2032)
  6. 4.2.4 Global Agomelatine API Revenue Market Share by Region (2021-2032)
  7. 4.3 Global Agomelatine API Sales Estimates and Forecasts 2021-2032
  8. 4.4 Global Agomelatine API Sales by Region
  9. 4.4.1 Global Agomelatine API Sales by Region: 2021 VS 2025 VS 2032
  10. 4.4.2 Global Agomelatine API Sales by Region (2021-2026)
  11. 4.4.3 Global Agomelatine API Sales by Region (2027-2032)
  12. 4.4.4 Global Agomelatine API Sales Market Share by Region (2021-2032)
  13. 4.5 North America
  14. 4.6 Europe
  15. 4.7 China
  16. 4.8 Asia (Excluding China)
  17. 4.9 South America, Middle East and Africa
5 Market Competitive Landscape by Manufacturers
  1. 5.1 Global Agomelatine API Revenue by Manufacturers
  2. 5.1.1 Global Agomelatine API Revenue by Manufacturers (2021-2026)
  3. 5.1.2 Global Agomelatine API Revenue Market Share by Manufacturers (2021-2026)
  4. 5.1.3 Global Agomelatine API Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 5.2 Global Agomelatine API Sales by Manufacturers
  6. 5.2.1 Global Agomelatine API Sales by Manufacturers (2021-2026)
  7. 5.2.2 Global Agomelatine API Sales Market Share by Manufacturers (2021-2026)
  8. 5.2.3 Global Agomelatine API Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 5.3 Global Agomelatine API Sales Price by Manufacturers (2021-2026)
  10. 5.4 Global Agomelatine API Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 5.5 Global Agomelatine API Key Manufacturers Manufacturing Sites & Headquarters
  12. 5.6 Global Agomelatine API Manufacturers, Product Type & Application
  13. 5.7 Global Agomelatine API Manufacturers Commercialization Time
  14. 5.8 Market Competitive Analysis
  15. 5.8.1 Global Agomelatine API Market CR5 and HHI
  16. 5.8.2 2025 Agomelatine API Tier 1, Tier 2, and Tier 3
6 Agomelatine API Market by Type
  1. 6.1 Global Agomelatine API Revenue by Type
  2. 6.1.1 Global Agomelatine API Revenue by Type (2021-2032) & (US$ Million)
  3. 6.1.2 Global Agomelatine API Revenue Market Share by Type (2021-2032)
  4. 6.2 Global Agomelatine API Sales by Type
  5. 6.2.1 Global Agomelatine API Sales by Type (2021-2032) & (Tons)
  6. 6.2.2 Global Agomelatine API Sales Market Share by Type (2021-2032)
  7. 6.3 Global Agomelatine API Price by Type
7 Agomelatine API Market by Application
  1. 7.1 Global Agomelatine API Revenue by Application
  2. 7.1.1 Global Agomelatine API Revenue by Application (2021-2032) & (US$ Million)
  3. 7.1.2 Global Agomelatine API Revenue Market Share by Application (2021-2032)
  4. 7.2 Global Agomelatine API Sales by Application
  5. 7.2.1 Global Agomelatine API Sales by Application (2021-2032) & (Tons)
  6. 7.2.2 Global Agomelatine API Sales Market Share by Application (2021-2032)
  7. 7.3 Global Agomelatine API Price by Application
8 Company Profiles
  1. 8.1 Msn Pharmachem Private Ltd
  2. 8.1.1 Msn Pharmachem Private Ltd Company Information
  3. 8.1.2 Msn Pharmachem Private Ltd Business Overview
  4. 8.1.3 Msn Pharmachem Private Ltd Agomelatine API Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 8.1.4 Msn Pharmachem Private Ltd Agomelatine API Product Portfolio
  6. 8.1.5 Msn Pharmachem Private Ltd Recent Developments
  7. 8.2 Jiangsu Hansoh Pharmaceutical Group
  8. 8.2.1 Jiangsu Hansoh Pharmaceutical Group Company Information
  9. 8.2.2 Jiangsu Hansoh Pharmaceutical Group Business Overview
  10. 8.2.3 Jiangsu Hansoh Pharmaceutical Group Agomelatine API Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Hansoh Pharmaceutical Group Agomelatine API Product Portfolio
  12. 8.2.5 Jiangsu Hansoh Pharmaceutical Group Recent Developments
  13. 8.3 Yangtze River Pharmaceutical
  14. 8.3.1 Yangtze River Pharmaceutical Company Information
  15. 8.3.2 Yangtze River Pharmaceutical Business Overview
  16. 8.3.3 Yangtze River Pharmaceutical Agomelatine API Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 8.3.4 Yangtze River Pharmaceutical Agomelatine API Product Portfolio
  18. 8.3.5 Yangtze River Pharmaceutical Recent Developments
9 North America
  1. 9.1 North America Agomelatine API Market Size by Type
  2. 9.1.1 North America Agomelatine API Revenue by Type (2021-2032)
  3. 9.1.2 North America Agomelatine API Sales by Type (2021-2032)
  4. 9.1.3 North America Agomelatine API Price by Type (2021-2032)
  5. 9.2 North America Agomelatine API Market Size by Application
  6. 9.2.1 North America Agomelatine API Revenue by Application (2021-2032)
  7. 9.2.2 North America Agomelatine API Sales by Application (2021-2032)
  8. 9.2.3 North America Agomelatine API Price by Application (2021-2032)
  9. 9.3 North America Agomelatine API Market Size by Country
  10. 9.3.1 North America Agomelatine API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 North America Agomelatine API Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 North America Agomelatine API Price by Country (2021-2032)
  13. 9.3.4 United States
  14. 9.3.5 Canada
  15. 9.3.6 Mexico
10 Europe
  1. 10.1 Europe Agomelatine API Market Size by Type
  2. 10.1.1 Europe Agomelatine API Revenue by Type (2021-2032)
  3. 10.1.2 Europe Agomelatine API Sales by Type (2021-2032)
  4. 10.1.3 Europe Agomelatine API Price by Type (2021-2032)
  5. 10.2 Europe Agomelatine API Market Size by Application
  6. 10.2.1 Europe Agomelatine API Revenue by Application (2021-2032)
  7. 10.2.2 Europe Agomelatine API Sales by Application (2021-2032)
  8. 10.2.3 Europe Agomelatine API Price by Application (2021-2032)
  9. 10.3 Europe Agomelatine API Market Size by Country
  10. 10.3.1 Europe Agomelatine API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 10.3.2 Europe Agomelatine API Sales by Country (2021 VS 2025 VS 2032)
  12. 10.3.3 Europe Agomelatine API Price by Country (2021-2032)
  13. 10.3.4 Germany
  14. 10.3.5 France
  15. 10.3.6 U.K.
  16. 10.3.7 Italy
  17. 10.3.8 Russia
  18. 10.3.9 Spain
  19. 10.3.10 Netherlands
  20. 10.3.11 Switzerland
  21. 10.3.12 Sweden
11 China
  1. 11.1 China Agomelatine API Market Size by Type
  2. 11.1.1 China Agomelatine API Revenue by Type (2021-2032)
  3. 11.1.2 China Agomelatine API Sales by Type (2021-2032)
  4. 11.1.3 China Agomelatine API Price by Type (2021-2032)
  5. 11.2 China Agomelatine API Market Size by Application
  6. 11.2.1 China Agomelatine API Revenue by Application (2021-2032)
  7. 11.2.2 China Agomelatine API Sales by Application (2021-2032)
  8. 11.2.3 China Agomelatine API Price by Application (2021-2032)
12 Asia (Excluding China)
  1. 12.1 Asia Agomelatine API Market Size by Type
  2. 12.1.1 Asia Agomelatine API Revenue by Type (2021-2032)
  3. 12.1.2 Asia Agomelatine API Sales by Type (2021-2032)
  4. 12.1.3 Asia Agomelatine API Price by Type (2021-2032)
  5. 12.2 Asia Agomelatine API Market Size by Application
  6. 12.2.1 Asia Agomelatine API Revenue by Application (2021-2032)
  7. 12.2.2 Asia Agomelatine API Sales by Application (2021-2032)
  8. 12.2.3 Asia Agomelatine API Price by Application (2021-2032)
  9. 12.3 Asia Agomelatine API Market Size by Country
  10. 12.3.1 Asia Agomelatine API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 Asia Agomelatine API Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 Asia Agomelatine API Price by Country (2021-2032)
  13. 12.3.4 Japan
  14. 12.3.5 South Korea
  15. 12.3.6 India
  16. 12.3.7 Australia
  17. 12.3.8 Taiwan
  18. 12.3.9 Southeast Asia
13 South America, Middle East and Africa
  1. 13.1 SAMEA Agomelatine API Market Size by Type
  2. 13.1.1 SAMEA Agomelatine API Revenue by Type (2021-2032)
  3. 13.1.2 SAMEA Agomelatine API Sales by Type (2021-2032)
  4. 13.1.3 SAMEA Agomelatine API Price by Type (2021-2032)
  5. 13.2 SAMEA Agomelatine API Market Size by Application
  6. 13.2.1 SAMEA Agomelatine API Revenue by Application (2021-2032)
  7. 13.2.2 SAMEA Agomelatine API Sales by Application (2021-2032)
  8. 13.2.3 SAMEA Agomelatine API Price by Application (2021-2032)
  9. 13.3 SAMEA Agomelatine API Market Size by Country
  10. 13.3.1 SAMEA Agomelatine API Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 13.3.2 SAMEA Agomelatine API Sales by Country (2021 VS 2025 VS 2032)
  12. 13.3.3 SAMEA Agomelatine API Price by Country (2021-2032)
  13. 13.3.4 Brazil
  14. 13.3.5 Argentina
  15. 13.3.6 Chile
  16. 13.3.7 Colombia
  17. 13.3.8 Peru
  18. 13.3.9 Saudi Arabia
  19. 13.3.10 Israel
  20. 13.3.11 UAE
  21. 13.3.12 Turkey
  22. 13.3.13 Iran
  23. 13.3.14 Egypt
14 Value Chain and Sales Channels Analysis
  1. 14.1 Agomelatine API Value Chain Analysis
  2. 14.1.1 Agomelatine API Key Raw Materials
  3. 14.1.2 Raw Materials Key Suppliers
  4. 14.1.3 Manufacturing Cost Structure
  5. 14.1.4 Agomelatine API Production Mode & Process
  6. 14.2 Agomelatine API Sales Channels Analysis
  7. 14.2.1 Direct Comparison with Distribution Share
  8. 14.2.2 Agomelatine API Distributors
  9. 14.2.3 Agomelatine API Customers
15 Concluding Insights
    16 Appendix
    1. 16.1 Reasons for Doing This Study
    2. 16.2 Research Methodology
    3. 16.3 Research Process
    4. 16.4 Authors List of This Report
    5. 16.5 Data Source
    6. 16.5.1 Secondary Sources
    7. 16.5.2 Primary Sources
    8. 16.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst